Category:
Active Pharmaceutical Ingredients
CAS NO:
1446502-11-9
Standard:
ChP,
Research and development(R&D)
Enasidenib is a targeted small-molecule inhibitor developed for hematologic malignancies. Its core synthesis involves chiral resolution and specific heterocyclic coupling. Molecular Formula: C27H31N5O; CAS No.: 1408679-46-8.
Strictly contraindicated for patients with severe hepatic impairment. Store below 25°C in original sealed containers to prevent degradation. Monitor differentiation syndrome during clinical administration.